AMWL

American Well Corp
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$205.09M
P/E Ratio
—
EPS
$-3.43
Beta
1.69
52W High
$15.16
52W Low
$3.71
50-Day MA
$12.96
200-Day MA
$9.08
Dividend Yield
—
Profit Margin
-27.00%
Forward P/E
—
PEG Ratio
—

About American Well Corp

American Well Corporation is a telehealth business enabling digital healthcare delivery. The company is headquartered in Boston, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$211.23M
Gross Profit (TTM)$110.18M
EBITDA$-30.26M
Operating Margin-23.80%
Return on Equity-22.80%
Return on Assets-11.00%
Revenue/Share (TTM)$12.64
Book Value$12.35
Price-to-Book0.98
Price-to-Sales (TTM)0.97
EV/Revenue0.141
EV/EBITDA-0.81
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-13.00%
Shares Outstanding$15.57M
Float$11.13M
% Insiders4.50%
% Institutions47.08%

Historical Volatility

HV 10-Day
94.62%
HV 20-Day
82.37%
HV 30-Day
72.26%
HV 60-Day
61.18%
HV Rank
65.9%

Volatility is currently expanding

Analyst Ratings

Consensus ($13.20 target)
1
Buy
6
Hold

Latest News

What American Well (AMWL) Said on Its Q3 Earnings Call

American Well NYSE: AMWL, known as Amwell, reported third-quarter 2026 revenue above its guidance range and narrowed its adjusted EBITDA loss as stronger visit volumes and cost controls helped support its target of reaching positive adjusted EBITDA and operating cash flow in the fourth quarter.

MarketBeat11/4/2026Positive
Amwell® Announces Results for the Third Quarter 2026

BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30, 2026. “Health plans and employers want engagement, outcomes and proof, and Amwell's single platform is built to deliver all three,” said Dr. Ido Schoenberg, Chairman and CEO of Amwell.

GlobeNewsWire11/3/2026Neutral
Discovery Health expanded access to mental healthcare for 22,000 members in one year, with better outcomes and lower hospital costs

BOSTON and JOHANNESBURG, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology-enabled care, today published a new case study on Discovery Health's use of SilverCloud® by Amwell® to deliver a fully funded digital mental health benefit in South Africa. The case study examines the three questions health plans ask of digital care: whether members will use it, whether it improves their health, and what it does to costs.

GlobeNewsWire10/14/2026Neutral
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure

BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced the Department of Veterans Affairs (VA) has declared its intent for the Company to deploy its virtual health platform within the VA enterprise and help power the modernization of the VA's digital health infrastructure.

GlobeNewsWire9/8/2026Neutral
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation

BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell's ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.

GlobeNewsWire9/3/2026Neutral
Amwell® to participate in upcoming investor conferences

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:

GlobeNewsWire9/2/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMWL and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026